Bone Biologics (OTC:BBLG – Get Rating) and Avanos Medical (NYSE:AVNS – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, risk, earnings, dividends and valuation. Insider and Institutional Ownership 7.6% of Bone Biologics shares […]
Bone Biologics (OTC:BBLG – Get Rating)‘s stock had its “buy” rating restated by equities research analysts at EF Hutton Acquisition Co. I in a report released on Thursday, Benzinga reports. They currently have a $2.25 price target on the stock. Bone Biologics Stock Down 2.4 % Shares of Bone Biologics stock traded down $0.01 on […]
EF Hutton Acquisition Co. I reaffirmed their buy rating on shares of Bone Biologics (OTC:BBLG – Get Rating) in a research note published on Thursday, Benzinga reports. They currently have a $2.25 price target on the stock. Bone Biologics Stock Performance OTC BBLG traded down $0.01 on Thursday, reaching $0.24. 4,039 shares of the company […]
Bone Biologics (OTC:BBLG – Get Rating)‘s stock had its “buy” rating restated by equities researchers at EF Hutton Acquisition Co. I in a research note issued to investors on Thursday, Benzinga reports. They presently have a $2.25 price objective on the stock. Bone Biologics Price Performance OTC BBLG traded down $0.01 on Thursday, hitting $0.24. […]